Advertisement
Home »

Omalizumab prevents respiratory illnesses in non-atopic chronic spontaneous urticaria patients: A prospective, parallel-group, pilot pragmatic trial.

Jul 25, 2023

ABOUT THE EXPERTS

  • George N Konstantinou

    Department of Allergy and Clinical Immunology, 424 General Military Training Hospital, Thessaloniki, Greece.

    Indrashis Podder

    Department of Allergy and Clinical Immunology, 424 General Military Training Hospital, Thessaloniki, Greece.

    Department of Dermatology, College of Medicine and Sagore Dutta Hospital, Kolkata, West Bengal, India.

    Dimitrios Karapiperis

    Department of Infectious Diseases, 424 General Military Training Hospital, Thessaloniki, Greece.

REFERENCES & ADDITIONAL READING

PubMed

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

Advertisement